Improving the spontaneous reporting of suspected adverse drug reactions: An overview of systematic reviews

被引:1
|
作者
Routledge, Philip Alexander [1 ]
Bracchi, Robert [2 ]
机构
[1] Cardiff Univ, Sch Med, Cardiff, Wales
[2] Univ Hosp Llandough, All Wales Therapeut & Toxicol Ctr, Llandough, Wales
关键词
adverse drug reaction reports; overview; systematic reviews; CLUSTER-RANDOMIZED TRIAL; TIME-SERIES ANALYSIS; THROMBOTIC MICROANGIOPATHY; EDUCATIONAL INTERVENTION; PHARMACOVIGILANCE; STRATEGIES; PHYSICIANS; PROGRAM;
D O I
10.1111/bcp.15791
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
AimTo conduct an overview of systematic reviews examining interventions to stimulate spontaneous reporting of suspected adverse drug reactions (ADRs) by healthcare professionals (HCPs) and/or patients/carers. MethodsSystematic reviews published since 1 January 2000 were identified and the included publications categorized in relation to the 4Es (education, engineering, economics and enforcement). ResultsAlmost all studies were aimed at HCPs. Educational initiatives were most often used and, in most studies, were associated with improvements in quantity and/or quality of reports, at least in the short term. Lectures/presentations and regular reminders (eg, verbal or by e-mail) were the educational methods most often identified by systematic reviews. Engineering initiatives were also generally effective, including improving the availability of reporting forms, electronic ADR reporting, modification of reporting procedures/policies or the reporting form and assistance to complete the form. Evidence for the benefit of economic incentives (eg, monetary rewards, lottery tickets, days off work, "giveaways" and educational credits) was often clouded by the potential effects of other concomitant initiatives, and any possible associated improvements often disappeared rapidly after incentives were discontinued. ConclusionEducational and engineering strategies appear to be the interventions most often associated with improvements in reporting rates by HCPs, at least in the short to medium term. However, the evidence for sustained impact is weak. The available data were insufficient to clearly identify the separate impact of economic strategies. Further work is also needed to examine the effects of these strategies on reporting by patients, carers and the public.
引用
收藏
页码:2377 / 2385
页数:9
相关论文
共 50 条
  • [1] Interventions to improve spontaneous adverse drug reaction reporting by healthcare professionals and patients: systematic review and meta-analysis
    Paudyal, Vibhu
    Al-Hamid, Abdullah
    Bowen, Matthew
    Hadi, Muhammad Abdul
    Hasan, Syed Shahzad
    Jalal, Zahraa
    Stewart, Derek
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (09) : 1173 - 1191
  • [2] Improving adverse drug event reporting by healthcare professionals
    Shalviri, Gloria
    Mohebbi, Niayesh
    Mirbaha, Fariba
    Majdzadeh, Reza
    Yazdizadeh, Bahareh
    Gholami, Kheirollah
    Grobler, Liesl
    Rose, Christopher J.
    Chin, Weng Yee
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (10):
  • [3] Improving the Reporting of Adverse Drug Reactions in the Hospital Setting
    Pushkin, Richard
    Frassetto, Lynda
    Tsourounis, Candy
    Segal, Eleanor S.
    Kim, Stephanie
    POSTGRADUATE MEDICINE, 2010, 122 (06) : 154 - 164
  • [4] Multifaceted interventions for improving spontaneous reporting of adverse drug reactions in a general hospital in China
    Fang, Huan
    Lin, Xiaowen
    Zhang, Jun
    Hong, Zhen
    Sugiyama, Kenji
    Nozaki, Takao
    Sameshima, Tetsuro
    Kobayashi, Susumu
    Namba, Hiroki
    Asakawa, Tetsuya
    BMC PHARMACOLOGY & TOXICOLOGY, 2017, 18
  • [5] Multifaceted interventions for improving spontaneous reporting of adverse drug reactions in a general hospital in China
    Huan Fang
    Xiaowen Lin
    Jun Zhang
    Zhen Hong
    Kenji Sugiyama
    Takao Nozaki
    Tetsuro Sameshima
    Susumu Kobayashi
    Hiroki Namba
    Tetsuya Asakawa
    BMC Pharmacology and Toxicology, 18
  • [6] Spontaneous reporting of adverse drug reactions: Who reports and what?
    Tubert-Bitter, P
    Haramburu, F
    Begaud, B
    Chaslerie, A
    Abraham, E
    Hagry, C
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 1998, 7 (05) : 323 - 329
  • [7] Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital
    Vallano, A
    Cereza, G
    Pedròs, C
    Agustí, A
    Danés, I
    Aguilera, C
    Arnau, JM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (06) : 653 - 658
  • [8] Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway
    Granas, Anne G.
    Buajordet, Marit
    Stenberg-Nilsen, Hanne
    Harg, Pernille
    Horn, Anne M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (04) : 429 - 434
  • [9] Suspected Adverse Drug Reactions Related to Breast Cancer Chemotherapy: Disproportionality Analysis of the Brazilian Spontaneous Reporting System
    Barcelos, Flavia Campos
    de Matos, Guacira Correa
    Sobreira da Silva, Mario Jorge
    Barbosa da Silva, Fabricio Alves
    Lima, Elisangela da Costa
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [10] Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future
    Alomar, Muaed
    Tawfiq, Ali M.
    Hassan, Nageeb
    Palaian, Subish
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2020, 11